Corcept Therapeutics
CORT
#2296
Rank
ยฃ6.11 B
Marketcap
ยฃ55.89
Share price
3.10%
Change (1 day)
-2.62%
Change (1 year)

EPS for Corcept Therapeutics (CORT)

EPS in 2023 (TTM): ยฃ0.71

According to Corcept Therapeutics 's latest financial reports the company's current EPS (TTM) is ยฃ0.39. In 2022 the company made an earnings per share (EPS) of ยฃ0.71 a decrease over its 2021 EPS that were of ยฃ0.72.

EPS history for Corcept Therapeutics from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ0.710.62%
2022ยฃ0.71-2.06%
2021ยฃ0.725.43%
2020ยฃ0.6910.84%
2019ยฃ0.6227.69%
2018ยฃ0.48-42.48%
2017ยฃ0.841518.29%
2016ยฃ0.05201-199.75%
2015-ยฃ0.05214-77.42%
2014-ยฃ0.23-32.61%
2013-ยฃ0.3412.2%
2012-ยฃ0.312.5%
2011-ยฃ0.302.56%
2010-ยฃ0.292.63%
2009-ยฃ0.28-11.63%
2008-ยฃ0.3226.47%
2007-ยฃ0.25-68.81%
2006-ยฃ0.8123.86%
2005-ยฃ0.66-1.12%
2004-ยฃ0.66-27.05%
2003-ยฃ0.91

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ4.98 1,185.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ3.91 909.62%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ0.57 46.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ22.99 5,835.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ0.74 90.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ3.37 769.23%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-ยฃ0.09684-125.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-ยฃ0.01490-103.85%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.28-26.92%๐Ÿ‡บ๐Ÿ‡ธ USA